A phase II study of weekly low-dose paclitaxel plus 24-hour infusion of cisplatin as first-line chemotherapy for metastatic breast cancer (MBC)

被引：0
|
作者：
Shen, Y. [1 ]
Hsu, C. [1 ]
Kuo, S. [1 ]
Lu, Y. [1 ]
Lin, C. [1 ]
Huang, C. [1 ]
Cheng, A. [1 ]
机构：
[1] Natl Taiwan Univ Hosp, Taipei, Taiwan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2007年 / 25卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1100
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Phase II study with cisplatin and paclitaxel in combination with weekly high-dose 24 h infusional 5-fluorouracil/leucovorin for first-line treatment of metastatic breast cancer
    Klaassen, U
    Wilke, H
    Weyhofen, R
    Harstrick, A
    Eberhardt, W
    Muller, C
    Korn, M
    Hanske, M
    Diergarten, K
    Seeber, S
    ANTI-CANCER DRUGS, 1998, 9 (03) : 203 - 207
  • [22] Phase II study of a weekly 24-hour infusion with 5-fluorouracil and simultaneous sodium-folinic acid in the first-line treatment of metastatic colorectal cancer
    Hartung, G
    Hofheinz, RD
    Wein, A
    Riedel, C
    Rost, A
    Fritze, D
    Kreuser, ED
    Drees, M
    Kühnel, J
    Hehlmann, R
    Queisser, W
    ONKOLOGIE, 2001, 24 (05): : 457 - 462
  • [23] Weekly paclitaxel as first-line chemotherapy for elderly patients with metastatic breast cancer. A multicentre phase II trial
    ten Tije, AJ
    Smorenburg, CH
    Seynaeve, C
    Sparrebooma, A
    Schothorst, KLC
    Kerkhofs, LGM
    van Reisen, LGPM
    Stoter, G
    Bontenbal, M
    Verweij, J
    EUROPEAN JOURNAL OF CANCER, 2004, 40 (03) : 352 - 357
  • [24] Preliminary results of a Phase II study of low dose weekly paclitaxel (TXL) plus high dose tremifene (TOR) in patients with metastatic breast cancer (MBC)
    不详
    EJC SUPPLEMENTS, 2006, 4 (02): : 169 - 169
  • [25] 1-hour infusion weekly Paclitaxel as first-line treatment in advanced breast cancer
    Ranuzzi, M
    Scirocchi, R
    Teodori, T
    Garritan, G
    Russo, F
    INTERNATIONAL JOURNAL OF CANCER, 2002, : 197 - 197
  • [26] Paclitaxel in combination with weekly 24-hour infusional 5-fluorouracil plus leucovorin in the second-line treatment of metastatic breast cancer: Results of a phase II study
    Klaassen, U
    Wilke, H
    Harstrick, A
    Pari, CP
    Strumberg, D
    Newmann, K
    Eberhardt, W
    Achterrath, W
    Lenaz, L
    Seeber, S
    ANNALS OF ONCOLOGY, 1998, 9 (01) : 45 - 50
  • [27] Phase II study of weekly paclitaxel and 24-hour infusion of high-dose 5-fluorouracil and leucovorin in the treatment of recurrent or metastatic gastric cancer
    Yeh, KH
    Lu, YS
    Hsu, CH
    Lin, JF
    Hsu, C
    Kuo, SH
    Li, SJ
    Cheng, AL
    ONCOLOGY, 2005, 69 (01) : 88 - 95
  • [28] Weekly 1-hour paclitaxel as first line chemotherapy for advanced and metastatic breast cancer
    Wist, EA
    Sommer, HH
    Oestenstad, B
    Risberg, T
    Fjaestad, K
    INTERNATIONAL JOURNAL OF CANCER, 2002, : 138 - 138
  • [29] Weekly paclitaxel, cisplatin, and 24-hour infusion of high-dose 5-fluorouracil plus leucovorin (weekly TP-HDFL) in patients with metastatic or recurrent esophageal cancer
    Huang, T.
    Tsai, Y.
    Lin, C.
    Cheng, A.
    Yeh, K.
    Hsu, C.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [30] A clinical phase II study of cisplatin and vinorelbine followed by docetaxel as first-line treatment in metastatic breast cancer (MBC).
    Yassine, H
    Khalifeh, M
    Bitar, N
    Charafeddine, M
    Dheiny, M
    Chehal, A
    Jalloul, R
    Dandashi, A
    Wehbeh, M
    Shamseddine, A
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 83S - 83S
12345